© 2019 bioProtonics, Inc. 

Scott Cannizzaro, Ph.D., MBA—CEO

Scott Cannizzaro is an accomplished leader in life science who partners with other executives, board-of-directors and entrepreneurs to translate and accelerate science and technology into products with compelling market positions.

   

As an experienced research scientist, he has always understood the need to harness science for its potential to serve and help move us forward.  Scott has significant experience across management consulting, venture capital, entrepreneurship and corporate strategy. 

Having worked in Cambridge, Massachusetts as a management consultant at Arthur D. Little and then at two start-up companies, both of which failed – lessons were learned early in his career.  Following this experience, Scott then spent a decade at Johnson & Johnson working across the pharmaceutical space in a venture capitalist role, identifying opportunities to develop early-stage assets and successfully advancing these programs into late stage product development.  Within Janssen Pharmaceuticals, he established and led the first cell therapy group; promoting the development of this novel asset class with J&J.

 Scott has been directly involved in every aspect of biotech/pharm operations; R&D, CMC manufacturing, preclinical and clinical development, product launch and marketing.  Scott has managed annual budget spends greater than $30M and served on the board of Johnson & Johnson’s Internal Venture Fund.

 Most notably, Scott co-founded Evolus.  He led the company from its inception through to IPO, FDA market approval, and product launch in only 5 years, resulting in a 5x return on a $50M investment.  The current market capitalization for the company is over $500M.

 Dr. Cannizzaro understands that success is fueled by collaboration and the assembly of great teams.  It is this aspect of his career that he holds in highest regard.  The management of a great team is the single most important element to ‘getting the science right’.

 Scott earned his PhD in physical organic chemistry at Duke University, studying mechanisms in free radical polymerizations.  He went on to study drug delivery and biomedical and tissue engineering with Prof. Robert Langer at MIT as an NIH post-doctoral fellow.  His formal scientific training is complimented by an MBA, earned at the Wharton School, University of Pennsylvania, where he majored in Health Care.

Timothy James, PhD - CTO and Founder

Dr James has extensive experience leading product, market, and business development efforts in technologically complex markets—in particular, those requiring product solutions based on disparate technologies and in environments where industry dynamics and professional politics are as important as product performance (e.g., medical technology). He has repeatedly demonstrated the ability to ascertain fundamental market needs, to evaluate technological approaches, and to guide product and business development efforts accordingly—i.e., match the technologically possible to the economically important. His experience encompasses several technological disciplines, including magnetic resonance imaging (MRI) and its medical applications (three FDA 510Ks), MRI market dynamics towards development and marketing of an in-office MRI scanner, development of cryogenic low noise antennas for MRI, and the physics and signal processing required for microscopic biologic tissue texture diagnostic assessment, using magnetic resonance-based techniques. Over the past 20+ years, Tim has focused on applying technology to new market opportunities. This included leading the effort to develop a digital x-ray imager based on underlying thin film transistor technology.

Kristin James, PhD EE - Chief Strategy Officer/Chief Research Officer and Founder
Dr. James is responsible for a large share of the company’s current IP position, including ongoing patent development and protection. She is a key contributor to strategic analysis and optimal positioning of the bioProtonics’ technology in the rapidly shifting healthcare market and has led the effort to identify and develop primary clinical applications to position µTexture as a game-changer in the diagnostic field.
Work in her past life encompassed technology development/project management in fields as diverse as clinical development and staging for a novel biomedical diagnostic, room temperature radiation detector development, optical properties of semiconductor materials as crystalline defect markers, and identification of damage mechanisms in composite materials. Dr James is a Howard Hughes Research Fellowship recipient and holds several patents/ peer-reviewed publications.

Daniel R. Doiron, PhD - Chairman of the Board

Founder & Executive Chairman.  35 years of entrepreneurial experience in early stage medical technology companies, include two IPOs.   Extensive experience in IP and technology licensing with large pharmaceutical and medical device companies.

Education: 1972:    BS, Nuclear Engineering, University of California, Santa Barbara 1976:  MS, Nuclear Engineering, University of California, Santa Barbara 1982:    PhD, Chemical Engineering, University of California, Santa Barbara.

Charles W. Winckler- CFO

Mr. Winckler brings over 20 years of industry experience in venture backed technology companies.  Mr. Winckler is currently or recently held the positions of interim CFO and/or Senior Financial Advisor at numerous technology start-ups. He has acted as a senior financial consultant on several mergers and acquisitions and complex financial transactions during this time.  Prior to his involvement with venture backed technology companies, Mr. Winckler was a manager with Ernst & Young LLP's financial advisory services practice. During his four years in the financial advisory services practice, he participated in a number of engagements in the manufacturing, high-tech and media/entertainment industries and gained significant exposure to issues regarding financial and operational matters. Before joining Ernst & Young LLP's Financial Advisory Services Group, he spent over two years in Ernst & Young's information, communications and entertainment audit practice where his clients ranged from start-up ventures to major public companies with SEC reporting requirements.  

Julia Huffman - Administrator/Accounting

Small Business & Start-up Specialist, Full-Charge Bookkeeper, Human Resources Generalist, Government Contracts, Investor Relations. Julia brings over 30 years of experience in managing small businesses.  Starting with her own retail establishment on State Street in Santa Barbara for over 20 years, then moving on to providing support services to management of other small businesses.